- |||||||||| Trial completion date, Trial primary completion date: Narrow Band Imaging Project on Barrett's Esophagus (clinicaltrials.gov) - Mar 16, 2023
P=N/A, N=50, Suspended, Trial completion date: Jan 2028 --> Jan 2030 | Trial primary completion date: Jan 2025 --> Jan 2030 Trial completion date: Dec 2019 --> Dec 2025 | Trial primary completion date: Dec 2019 --> Dec 2024
- |||||||||| Trial completion, Metastases: Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach (clinicaltrials.gov) - Apr 20, 2019
P2, N=61, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: TECR & ECM Placement for Esophageal High Grade Dysplasia (clinicaltrials.gov) - Mar 19, 2019
P=N/A, N=1, Terminated, Recruiting --> Completed | N=30 --> 51 N=10 --> 1 | Recruiting --> Terminated | Trial primary completion date: Mar 2017 --> Mar 2018; Serious Adverse Event of Patient who completed study and follow-up.
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Head and Neck Cancer Treatment Related Dysphagia (clinicaltrials.gov) - Mar 18, 2019
P=N/A, N=0, Withdrawn, Recruiting --> Completed | N=51 --> 81 N=250 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2019 --> Jun 2017
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Early Integration of Palliative Care in Esophageal Cancer Patients (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=12, Terminated, Active, not recruiting --> Completed | Trial completion date: May 2020 --> Feb 2019 N=120 --> 12 | Trial completion date: Dec 2019 --> Mar 2019 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Mar 2019; Study futility with regards to recruitment
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: HX4 SD: Tumor Hypoxia With HX4 PET in Several Diseases (clinicaltrials.gov) - Mar 8, 2019
P2, N=1, Terminated, N=120 --> 20 | Recruiting --> Completed N=120 --> 1 | Trial completion date: Jun 2020 --> May 2017 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> May 2017; patients did not want to participate
- |||||||||| Trial completion, Trial primary completion date: a4b7 Integrin in Eosinophilic Esophagitis (clinicaltrials.gov) - Feb 21, 2019
P=N/A, N=16, Completed, N=100 --> 4 | Trial completion date: Dec 2018 --> Feb 2017 | Recruiting --> Terminated; Was not able to recruit the total anticipated number of subjects Active, not recruiting --> Completed | Trial primary completion date: Jul 2018 --> Dec 2018
- |||||||||| Gastrocrom (cromolyn) / Viatris
Trial termination: Cromolyn Detection of Silent Aspiration (clinicaltrials.gov) - Feb 16, 2019 P1, N=16, Terminated, Recruiting --> Completed Recruiting --> Terminated; Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation.
- |||||||||| Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial completion, Combination therapy: Study of S-1 in Combination With Radiotherapy in Esophageal Cancer (clinicaltrials.gov) - Feb 16, 2019 P2, N=105, Completed, Recruiting --> Terminated; Difficulty recruiting; Funding ended; interim analysis provided sufficient data for interpretation. Active, not recruiting --> Completed
- |||||||||| esomeprazole / Generic mfg.
Trial completion, Trial completion date: BRAVO Study for Functional Dyspepsia (clinicaltrials.gov) - Jan 31, 2019 P4, N=130, Completed, Recruiting --> Completed | N=1000 --> 363 | Trial completion date: Jun 2019 --> Dec 2018 | Trial primary completion date: Jun 2019 --> Dec 2018 Recruiting --> Completed | Trial completion date: Dec 2017 --> Jul 2018
- |||||||||| Biomarker, Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis (clinicaltrials.gov) - Jan 30, 2019
P=N/A, N=28, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=50 --> 28 | Trial completion date: May 2018 --> Dec 2018 | Trial primary completion date: May 2018 --> Dec 2018
- |||||||||| Trial completion, Trial completion date: SIRUP: Stretta In Reflux Uncontrolled by IPP (clinicaltrials.gov) - Jan 29, 2019
P=N/A, N=62, Completed, Recruiting --> Completed | N=50 --> 28 | Trial completion date: May 2018 --> Dec 2018 | Trial primary completion date: May 2018 --> Dec 2018 Recruiting --> Completed | Trial completion date: May 2019 --> Nov 2018
- |||||||||| cisplatin / Generic mfg.
Trial termination, Biopsy: CHFR Methylation Status Esophageal Cancer Study (clinicaltrials.gov) - Jan 25, 2019 P2, N=31, Terminated, Recruiting --> Completed | N=120 --> 35 Active, not recruiting --> Terminated; Study stopped due to early stopping rule
- |||||||||| Trial completion date, Trial suspension, Trial primary completion date: Narrow Band Imaging Project on Barrett's Esophagus (clinicaltrials.gov) - Jan 25, 2019
P=N/A, N=50, Suspended, Active, not recruiting --> Terminated; Study stopped due to early stopping rule Trial completion date: Dec 2018 --> Dec 2019 | Recruiting --> Suspended | Trial primary completion date: Dec 2018 --> Dec 2019
- |||||||||| 5-fluorouracil / Generic mfg., cisplatin / Generic mfg., docetaxel / Generic mfg.
Biomarker, Trial completion, Enrollment change, Trial completion date, Metastases: Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. (clinicaltrials.gov) - Jan 25, 2019 P2, N=21, Completed, Trial completion date: Dec 2018 --> Dec 2019 | Recruiting --> Suspended | Trial primary completion date: Dec 2018 --> Dec 2019 Recruiting --> Completed | N=127 --> 21 | Trial completion date: Nov 2019 --> Apr 2017
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=1, Completed, Recruiting --> Completed | N=127 --> 21 | Trial completion date: Nov 2019 --> Apr 2017 Withdrawn --> Completed | Trial completion date: Jul 2018 --> Aug 2017 | Trial primary completion date: Jul 2018 --> Aug 2017
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: A Validation Study of the Dx-pH Probe in Children for the Detection of Extra-oesophageal Reflux (clinicaltrials.gov) - Jan 19, 2019
P=N/A, N=16, Completed, Recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2018 | Trial primary completion date: Aug 2018 --> Dec 2018 Active, not recruiting --> Completed | N=30 --> 16 | Trial completion date: Jan 2016 --> Apr 2017 | Trial primary completion date: Jan 2016 --> Apr 2017
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Secondary Prophylaxis of Gastric Variceal Bleed (clinicaltrials.gov) - Jan 8, 2019
P=N/A, N=64, Completed, N=50 --> 24 | Trial completion date: Jan 2021 --> Nov 2018 | Recruiting --> Terminated; Study terminated due to low accrual. Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019 | Trial primary completion date: Jun 2018 --> Feb 2018
- |||||||||| Movantik (naloxegol) / AstraZeneca, RedHill, Kyowa Kirin
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Movantik for Opioid-Related Esophageal Disorders (clinicaltrials.gov) - Dec 24, 2018 P2, N=2, Terminated, Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2019 | Trial primary completion date: Jun 2018 --> Feb 2018 N=50 --> 2 | Trial completion date: Jan 2020 --> Oct 2018 | Recruiting --> Terminated | Trial primary completion date: Jan 2019 --> Oct 2018; Investigator left Institution
- |||||||||| cisplatin / Generic mfg., paclitaxel / Generic mfg., gefitinib / Generic mfg.
Enrollment change, Surgery, Metastases: Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery (clinicaltrials.gov) - Dec 6, 2018 P2, N=19, Terminated, Active, not recruiting --> Completed N=36 --> 19
- |||||||||| Trial completion, Phase classification, Trial completion date: Study to Image the Esophagus Using the OFDI Capsule (clinicaltrials.gov) - Dec 5, 2018
P=N/A, N=54, Completed, N=36 --> 19 Recruiting --> Completed | Phase classification: P1 --> PN/A | Trial completion date: Oct 2018 --> Jul 2016
- |||||||||| lansoprazole / Generic mfg., omeprazole / Generic mfg., esomeprazole / Generic mfg.
Biomarker, Trial completion: Implementation of PPI Medication PGX Testing (clinicaltrials.gov) - Nov 21, 2018 P4, N=28, Completed, Trial completion date: Jan 2020 --> Jan 2024 | Trial primary completion date: Oct 2019 --> Oct 2023 Active, not recruiting --> Completed
|